 |
|||||||||||||||||||||||||||||||||||||||||||||||||
   |
Coverage of 2008
|
||||||||||||||||||||||||||||||||||||||||||||||||
Abacavir controversy continues to brew |
|
Heat stable formulation of Norvir appears likely |
|
TB studies further identify risk factors for TB while on HAART |
|
Interferon gamma may lead to new option for treating tuberculosis |
|
TRIO study’s novel combination shows promise |
|
Elite controllers may show way to a cure |
Thursday, August 7
Tony Fauci lends support to focus on cure |
|
High HPV rate in MSM calls for new screening protocols |
|
Two new NNRTIs enter the pipeline |
Wednesday, August 6
Intriguing IL2 study results may offer unique solution |
|
Anti-depressants not linked to possibly increasing the risk of cancer |
|
Oral conditions and immune markers may help better define IRIS |
|
Milk thistle may help improve liver health in people with HIV and hepatitis C |
Tuesday, August 5
Researcher presents vexing information on Tibotec’s rilpivarine |
|
Mexican study may forecast advanced naíves |
|
Apricitabine continues to show good results |
|
Immune based therapy study offers intriguing possibility |
Monday, August 4
Isentress gets another good grade |
|
The HIV vaccine research community rebuilds its agenda |
|
A cause for optimism: Microbicides pipeline shows promise |
Sunday, August 3
CDC unveils substantially higher rate of annual HIV infections |
|
HIV sexual transmission under HAART: |
Saturday, August 2
Paul Dalton comments on activist Laurie Garrett's take on not attending the 2008 International Conference |
For other coverage of the 2008 International AIDS Conference, go to Kaiser Family Foundation.
IN THE NEWS
ARCHIVES
CONFERENCE
COVERAGE
2008 Int'l Conference
PROJECT INFORM
CITED IN MEDIA
© 2008 Project Inform 1375 Mission
Street, San Francisco, CA 94103 415-558-8669
National HIV/AIDS Treatment Hotline 1-800-822-7422 (415-558-9051 local/int'l) 10a-4p Mon-Fri PST